Pfizer is conducting layoffs at its Boulder, CO research facility, months after announcing a retreat from a significant chunk of its early-stage research.
The permanent separations will occur on Dec. 4, though Pfizer has not disclosed an exact number, according to Colorado’s WARN system. A company spokesperson declined to provide additional information on the number of layoffs and units affected. Some research programs will be transitioned to other facilities as part of the restructuring, according to the spokesperson.
“Pfizer continues to hone its R&D footprint and focus on areas where its capabilities are differentiated, aiming to reduce cycle times further through optimization of its end-to-end R&D operations,” the spokesperson said on Tuesday.
Financial news site Barron’s first reported earlier this year that Pfizer was backing out of some of its early research, including programs in certain rare diseases, gene therapies and cancer. The pharma giant confirmed…
Click here to view original post
